351 related articles for article (PubMed ID: 9348546)
1. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
Primus RJ; Yevich E; Baltazar C; Gallager DW
Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
[TBL] [Abstract][Full Text] [Related]
2. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain.
Sánchez MM; Young LJ; Plotsky PM; Insel TR
J Comp Neurol; 1999 Jun; 408(3):365-77. PubMed ID: 10340512
[TBL] [Abstract][Full Text] [Related]
4. Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay.
Ardati A; Goetschy V; Gottowick J; Henriot S; Valdenaire O; Deuschle U; Kilpatrick GJ
Neuropharmacology; 1999 Mar; 38(3):441-8. PubMed ID: 10219982
[TBL] [Abstract][Full Text] [Related]
5. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
McCarthy JR; Heinrichs SC; Grigoriadis DE
Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
[TBL] [Abstract][Full Text] [Related]
6. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
[TBL] [Abstract][Full Text] [Related]
7. Distribution of corticotropin-releasing factor (CRF) receptor binding in the mouse brain using a new, high-affinity radioligand, [
Tan LA; Vaughan JM; Perrin MH; Rivier JE; Sawchenko PE
J Comp Neurol; 2017 Dec; 525(18):3840-3864. PubMed ID: 28842924
[TBL] [Abstract][Full Text] [Related]
8. Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization.
Oshida Y; Ikeda Y; Chaki S; Okuyama S
Life Sci; 2004 Feb; 74(15):1911-24. PubMed ID: 14761672
[TBL] [Abstract][Full Text] [Related]
9. Characterization of [125I]sauvagine binding to CRH2 receptors: membrane homogenate and autoradiographic studies.
Rominger DH; Rominger CM; Fitzgerald LW; Grzanna R; Largent BL; Zaczek R
J Pharmacol Exp Ther; 1998 Jul; 286(1):459-68. PubMed ID: 9655891
[TBL] [Abstract][Full Text] [Related]
10. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.
Martinez V; Barquist E; Rivier J; Taché Y
Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279
[TBL] [Abstract][Full Text] [Related]
11. Characterisation using microphysiometry of CRF receptor pharmacology.
Smart D; Coppell A; Rossant C; Hall M; McKnight AT
Eur J Pharmacol; 1999 Aug; 379(2-3):229-35. PubMed ID: 10497910
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.
Lovenberg TW; Liaw CW; Grigoriadis DE; Clevenger W; Chalmers DT; De Souza EB; Oltersdorf T
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):836-40. PubMed ID: 7846062
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid.
Liaw CW; Lovenberg TW; Barry G; Oltersdorf T; Grigoriadis DE; de Souza EB
Endocrinology; 1996 Jan; 137(1):72-7. PubMed ID: 8536644
[TBL] [Abstract][Full Text] [Related]
14. Selective impairment of corticotropin-releasing factor1 (CRF1) receptor-mediated function using CRF coupled to saporin.
Maciejewski-Lenoir D; Heinrichs SC; Liu XJ; Ling N; Tucker A; Xie Q; Lappi DA; Grigoriadis DE
Endocrinology; 2000 Feb; 141(2):498-504. PubMed ID: 10650928
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
Myers DA; Trinh JV; Myers TR
Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
[TBL] [Abstract][Full Text] [Related]
16. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression.
Chalmers DT; Lovenberg TW; De Souza EB
J Neurosci; 1995 Oct; 15(10):6340-50. PubMed ID: 7472399
[TBL] [Abstract][Full Text] [Related]
17. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.
Mansi JA; Rivest S; Drolet G
Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325
[TBL] [Abstract][Full Text] [Related]
18. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine.
Porcher C; Juhem A; Peinnequin A; Sinniger V; Bonaz B
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1091-103. PubMed ID: 15637181
[TBL] [Abstract][Full Text] [Related]
19. Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands.
Hoare SR; Sullivan SK; Pahuja A; Ling N; Crowe PD; Grigoriadis DE
Peptides; 2003 Dec; 24(12):1881-97. PubMed ID: 15127940
[TBL] [Abstract][Full Text] [Related]
20. A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats.
Million M; Grigoriadis DE; Sullivan S; Crowe PD; McRoberts JA; Zhou H; Saunders PR; Maillot C; Mayer EA; Taché Y
Brain Res; 2003 Sep; 985(1):32-42. PubMed ID: 12957366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
